Patients carrying one copy of the CYP3A4*20 allele in combination with one copy of the *1 allele may have decreased metabolism of tacrolimus as compared to patients carrying two copies of the *1 allele. This annotation only covers the pharmacokinetic relationship between CYP3A4 and tacrolimus and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence tacrolimus metabolism.